McFerran, Ethna
Cairnduff, Victoria
Elder, Ray
Gavin, Anna
Lawler, Mark
Article History
Received: 1 September 2022
Accepted: 6 February 2023
First Online: 4 March 2023
Declarations
:
: This study used secondary data sources, the study received approval from the Northern Ireland Cancer Registry, and no patient-level consent was required.
: In line with the above approvals, Northern Ireland Cancer Registry staff verified study outputs to ensure there were no risks of accidental identification of patients by the data characteristics presented for publication, in line with confidential disclosure practices.
: ML declares honoraria from Bayer, Carnall Farrar, EMD Serono, Novartis, Pfizer and Roche unrelated to this work. The other authors declare that there are no conflicts of interest.